Subscribe

VanEck - China New Economy ETF (CNEW.AX)

AUD7.94 -0.21 (-2.58%)
ASX AUD AU Equity
NAV AUD 8.09 -1.85% vs NAV as of 2026-07-13
AUM AUD 101.80M
TER 0.95%
Yield (TTM) 0.76%
Distribution Distributing · Annual
52-week range 7.33 – 8.53
Holdings 121
Issuer VanEck

About this ETF

The VanEck - China New Economy ETF (CNEW) offers investors a curated portfolio of approximately 120 Chinese companies. These enterprises are chosen for their strong fundamentals, attractive valuations, and significant growth prospects within China's evolving 'New Economy' landscape, specifically across the technology, healthcare, consumer staples, and consumer discretionary sectors. The fund's primary aim is to replicate the performance of its benchmark index, prior to the deduction of fees and other expenses.

ISIN AU0000028185
Issuer VanEck
Domicile AU
Inception 2018-11-08
Asset class Equity

Price

Top 10 holdings

Suzhou Zelgen Biopharmaceutical Co Ltd 688266.SS 1.33%
Haisco Pharmaceutical Group Co Ltd 002653.SZ 1.19%
Shanghai Allist Pharmaceuticals Co Ltd 688578.SS 1.16%
Gempharmatech Co Ltd 1.14%
Sunshine Guojian Pharmaceutical Shangha 688336.SS 1.11%
Hitgen Inc 1.10%
Betta Pharmaceuticals Co Ltd 300558.SZ 1.10%
Aidite Qinhuangdao Technology Co Ltd 301580.SZ 1.08%
Suzhou Sepax Technologies Co Ltd 1.08%
Rockchip Electronics Co Ltd 603893.SS 1.05%
See full holdings →